Excess TPX2 Interferes with Microtubule Disassembly and Nuclei Reformation at Mitotic Exit.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
06 02 2020
Historique:
received: 20 12 2019
revised: 24 01 2020
accepted: 29 01 2020
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 11 2 2021
Statut: epublish

Résumé

The microtubule-associated protein TPX2 is a key mitotic regulator that contributes through distinct pathways to spindle assembly. A well-characterised function of TPX2 is the activation, stabilisation and spindle localisation of the Aurora-A kinase. High levels of TPX2 are reported in tumours and the effects of its overexpression have been investigated in cancer cell lines, while little is known in non-transformed cells. Here we studied TPX2 overexpression in hTERT RPE-1 cells, using either the full length TPX2 or a truncated form unable to bind Aurora-A, to identify effects that are dependent-or independent-on its interaction with the kinase. We observe significant defects in mitotic spindle assembly and progression through mitosis that are more severe when overexpressed TPX2 is able to interact with Aurora-A. Furthermore, we describe a peculiar, and Aurora-A-interaction-independent, phenotype in telophase cells, with aberrantly stable microtubules interfering with nuclear reconstitution and the assembly of a continuous lamin B1 network, resulting in daughter cells displaying doughnut-shaped nuclei. Our results using non-transformed cells thus reveal a previously uncharacterised consequence of abnormally high TPX2 levels on the correct microtubule cytoskeleton remodelling and G1 nuclei reformation, at the mitosis-to-interphase transition.

Identifiants

pubmed: 32041138
pii: cells9020374
doi: 10.3390/cells9020374
pmc: PMC7072206
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
Chromatin 0
Lamin Type B 0
Microtubule-Associated Proteins 0
TPX2 protein, human 0
Aurora Kinase A EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R004137/1
Pays : United Kingdom

Références

Nature. 2019 Dec;576(7785):158-162
pubmed: 31776509
J Cell Sci. 2019 May 16;132(10):
pubmed: 31028180
Elife. 2020 Jan 14;9:
pubmed: 31933480
J Mol Biol. 2016 May 22;428(10 Pt A):1962-85
pubmed: 26423234
J Cell Sci. 2004 Dec 15;117(Pt 26):6511-22
pubmed: 15572412
EMBO J. 2003 May 1;22(9):2060-70
pubmed: 12727873
Cell. 2001 Jan 12;104(1):83-93
pubmed: 11163242
Chromosoma. 1998 Dec;107(6-7):479-85
pubmed: 9914380
Open Biol. 2013 Sep 04;3(9):130097
pubmed: 24004664
Cancer Res. 2012 Mar 15;72(6):1518-28
pubmed: 22266221
Cell Mol Life Sci. 2014 Aug;71(16):3027-47
pubmed: 24556998
Curr Biol. 2002 Dec 10;12(23):2055-9
pubmed: 12477396
Science. 2016 Apr 15;352(6283):353-8
pubmed: 27013428
Nucleus. 2014 Jan-Feb;5(1):40-6
pubmed: 24637392
Elife. 2017 Nov 09;6:
pubmed: 29120325
Biochim Biophys Acta. 2010 Dec;1806(2):230-9
pubmed: 20708655
J Cell Sci. 2016 Apr 1;129(7):1319-28
pubmed: 26869224
Mol Cell Biol. 2015 Mar;35(5):884-98
pubmed: 25535332
Chromosoma. 2016 Sep;125(4):607-19
pubmed: 26728621
Methods Appl Fluoresc. 2015 Jan 16;3(1):014002
pubmed: 29148478
Curr Opin Cell Biol. 2015 Aug;35:78-90
pubmed: 25982429
Carcinogenesis. 2007 May;28(5):899-912
pubmed: 17259655
Dev Biol. 2014 Jul 1;391(1):81-8
pubmed: 24709321
J Cell Biol. 1998 Nov 2;143(3):673-85
pubmed: 9813089
Front Oncol. 2015 Dec 21;5:290
pubmed: 26734572
Mol Cell. 2003 Oct;12(4):851-62
pubmed: 14580337
Nat Cell Biol. 2015 Nov;17(11):1422-34
pubmed: 26414402
J Cell Biol. 2008 Jul 14;182(1):77-88
pubmed: 18606852
Cell Cycle. 2013 Apr 1;12(7):1030-41
pubmed: 23428904
Biol Cell. 2017 Oct;109(10):364-374
pubmed: 28799169
J Cell Biol. 2003 Jan 6;160(1):25-39
pubmed: 12515822
Sci Signal. 2018 Aug 14;11(543):
pubmed: 30108183
J Opt Soc Am A Opt Image Sci Vis. 2016 Jul 1;33(7):B12-20
pubmed: 27409703
Nat Rev Mol Cell Biol. 2017 Mar;18(3):187-201
pubmed: 28174430
J Cell Sci. 1993 May;105 ( Pt 1):145-56
pubmed: 8360269
Nat Cell Biol. 2015 Jul;17(7):907-16
pubmed: 26098575
Oncogenesis. 2019 Apr 15;8(5):29
pubmed: 30988276
Dev Cell. 2018 Dec 3;47(5):547-563.e6
pubmed: 30513301
Science. 2016 Apr 15;352(6283):359-62
pubmed: 27013426
J Cell Biol. 2008 Jul 28;182(2):289-300
pubmed: 18663142
EMBO Rep. 2018 Aug;19(8):
pubmed: 29925526
J Cell Biol. 2006 Jun 5;173(5):685-94
pubmed: 16735579
Cell. 2013 Feb 14;152(4):768-77
pubmed: 23415226
Oncogene. 2019 Feb;38(6):852-867
pubmed: 30177840
Nat Genet. 2006 Sep;38(9):1043-8
pubmed: 16921376
J Cell Sci. 2011 Jan 1;124(Pt 1):113-22
pubmed: 21147853
Appl Opt. 2006 Jul 10;45(20):5037-45
pubmed: 16807615
J Cell Biol. 2011 Oct 3;195(1):87-98
pubmed: 21969468
Cell. 2017 May 18;169(5):780-791
pubmed: 28525751
Curr Biol. 2018 Jan 8;28(1):121-129.e4
pubmed: 29276125
Nat Cell Biol. 2002 Nov;4(11):871-9
pubmed: 12389033
Chemphyschem. 2014 Mar 17;15(4):794-800
pubmed: 24436314
J Cell Sci. 2012 Jan 1;125(Pt 1):133-43
pubmed: 22250201
J Cell Biol. 2003 Apr 28;161(2):281-94
pubmed: 12707311
J Cell Biol. 2017 Apr 3;216(4):983-997
pubmed: 28264915
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4997-5002
pubmed: 21383178
Cell Cycle. 2006 Feb;5(3):296-303
pubmed: 16418575
J Cell Biol. 2002 Aug 19;158(4):617-23
pubmed: 12177045
Mol Cell Biol. 2005 Dec;25(23):10516-27
pubmed: 16287863
Genes Chromosomes Cancer. 2012 Jun;51(6):545-56
pubmed: 22337647
Nature. 2015 Jun 11;522(7555):231-5
pubmed: 26040712
Biochem J. 2018 Jun 26;475(12):2025-2042
pubmed: 29946042
Mol Cell. 2014 Aug 21;55(4):578-91
pubmed: 25042804
Genes Cancer. 2012 Nov;3(11-12):721-30
pubmed: 23634259

Auteurs

Francesco D Naso (FD)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Valentina Sterbini (V)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Elena Crecca (E)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Italia A Asteriti (IA)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Alessandra D Russo (AD)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Maria Giubettini (M)

CrestOptics S.p.A., Via di Torre Rossa 66, 00165 Rome, Italy.
Center for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy.

Enrico Cundari (E)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Catherine Lindon (C)

Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.

Alessandro Rosa (A)

Center for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy.
Department of Biology and Biotechnology "C. Darwin", Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Giulia Guarguaglini (G)

Institute of Molecular Biology and Pathology, National Research Council of Italy, c/o Sapienza University of Rome, Via degli Apuli 4, 00185 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH